Find information on thousands of medical conditions and prescription drugs.

Syntocinon

Pitocin and Syntocinon are trademark names for injectable versions of the human hormone oxytocin. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
Growth hormone
Salbutamol
Salmeterol
Sandimmune
Sandostatin
Sansert
Saquinavir
Sarafem
Satric
Scopolamine
Seasonale
Secobarbital
Secretin
Selegiline
Semprex-D
Sensipar
Sensorcaine
Serax
Serevent
Serine
Seroquel
Serostim
Serrapeptase
Sertindole
Sertraline
Serzone
Sevelamer
Sevoflurane
Sibutramine
Sildenafil
Silibinin
Simvastatin
Sinemet
Sinequan
Singulair
Sirolimus
Skelaxin
Sodium cyclamate
Solage
Soma
Somatostatin
Sotahexal
Sotalol
Sotret
Spiperone
Spiriva
Spironolactone
Sporahexal
Sporanox
SPS
SSD
Stanozolol
Stavudine
Stelazine
Stilbestrol
Stilbetin
Stimate
Stiripentol
Strattera
Streptokinase
Streptomycin
Suboxone
Subutex
Sucralfate
Sucralfate
Sufentanil
Sulbactam
Sulfamethoxazole
Sulfanilamide
Sulfasalazine
Sulforidazine
Sulla
Sulpiride
Sultamicillin
Sumatriptan
Suprefact
Suramin sodium
Sustaire
Sustiva
Suxamethonium chloride
Symmetrel
Synarel
Synercid
Synthroid
Syntocinon
Zaleplon
T
U
V
W
X
Y
Z

Oxytocin is produced by pregnant women to cause the uterine contractions that precipitate childbirth. It may be administered if a doctor determines that, for any of a number of reasons, labor needs to be induced, or to hasten a difficult labor.

There have been questions raised about the safety and possible extensive overuse of this drug. Because it is introduced to the bloodstream continuously rather than in the periodic bursts with which the body would naturally release oxytocin, the decreased placental bloodflow that occurs as a side effect of a contraction is prolonged, and could deprive the baby of oxygen. If it stimulates excessively strong contraction leading to a violent and rapid delivery, oxytocin can potentially cause cervical lacerations, rupture of the uterus, postbirth hemorrhaging in the mother and other problems.

Read more at Wikipedia.org


[List your site here Free!]


Induction - of labor
From British Medical Journal, 4/10/99 by Geoffrey Chamberlain

Labour is induced when an external agent is used to stimulate delivery before the onset of spontaneous labour. Induction must be distinguished clearly from augmentation of labour: both use similar techniques, but the first aims to start labour, whereas the second enhances uterine contractions once labour has started.

Incidence

No statutory national data are collected on the incidence of induction. The National Birthday Trust's study on home births in 1994 showed a 19% induction rate among a normal group of women who planned to deliver in hospital compared with 0.2% in those who delivered at home. Hospital reports, where published, vary from 0% to 30%.

Indications

There are few absolute indications for inducing labour, and priorities vary with the obstetrician. Postmaturity (when the pregnancy extends well beyond the expected delivery date) still heads the list, followed by suspected fetal growth retardation and maternal hypertension. Social factors--such as the woman's own wishes--play a larger part these days.

In a meta-analysis of 10 randomised controlled trials comparing induction at 41-42 weeks with conservative treatment, Crowley showed the increased risk of perinatal deaths associated with prolonged pregnancy. The risk is reduced by induction at 41 weeks (Cochrane Collaboration).

A non-medical indication for induction is the woman's own wishes. Many mothers exceeding their expected delivery date by a week consider that their pregnancy has gone far enough and ask for induction. Roberts and Young found that about 70% of women expressed the wish to be induced after 41 weeks. Provided that the cervix is ripe, many obstetricians would agree with this choice and use a non-invasive method--for example, prostaglandins.

Maternal age and poor obstetric history are relative indications, but it should be remembered that induction is intended to result in a birth. Hence, if a vaginal delivery does not follow, a caesarean section may be required. If the grounds for induction are not strong, this could lead to a caesarean section for a poor indication.

Rarely, a planned time of delivery may be needed to provide the best care for the fetus. Some cardiac abnormalities may require immediate surgery after birth. Labour should be induced at a tertiary referral centre, with the facilities for neonatal surgery ready.

Readiness for induction

Before the obstetrician decides on induction and before he or she discusses the possibility with the woman, the uterus needs to be checked as ready for labour. This is best assessed by examining the lie and position of the fetus, the volume of amniotic fluid, the tone of the uterus, and the ripeness of the cervix, the last being the best predictor. Some of these clinical signs have been scored by Bishop (1964), to predict cervical assessment and the likelihood of the induction being successful.

If the score exceeds 8, the chance of a successful delivery after induction is the same as that following a spontaneous onset of labour. As with many scoring systems, the Bishop's score provides only a guide. A modest correlation exists between cervical ripeness and the likelihood of success. The Bishop's score only translates into numbers what the experienced clinician learns when examining the cervix for ripeness.

When planning an induction, the obstetrician should discuss the procedure fully with the woman, explaining the method to be used, any side effects, and the sequelae if it fails. She should give her informed consent to the procedure. It may be advisable for this to be in writing; if it is not, a note should be made by the doctor in the woman's records and signed.

Contraindications

Contraindications to induction are the same as contraindications to a vaginal delivery. A few are absolute (a severe degree of placenta praevia or a transverse fetal lie); others are relative, such as active primary genital herpes infection, or a high and floating fetal head as cord prolapse could follow.

Methods of induction

Fetal maturity should first be assessed. The presentation and position of the fetus should be rechecked just before induction.

The simplest procedure is to sweep the membranes with a gloved finger lubricated with antiseptic cream and inserted gently up the cervical canal. If performed by an experienced doctor or midwife, this need not be uncomfortable. After 40 weeks' gestation, this procedure can halve the subsequent need for further induction, but at 38-40 weeks it does not significantly increase the proportion of women who go into labour within 7 days.

The traditional method of induction is to rupture the membranes, releasing amniotic fluid. The forewaters can be snagged with a simple Amnihook (EMS Medical Group), a pair of Kocher's forceps, or a pair of special amniotomy forceps. Under sterile conditions the chosen instrument is passed through the cervical canal. Under vision or digital pilotage, the forewaters are snagged. The colour of the amniotic fluid and the volume released should be assessed. The fetal heart rate should be checked immediately afterwards to ensure no fetal compromise, but it is unnecessary to continue with cardiotocography unless there is a specific indication.

Puncture of the hindwaters used to be done with a Drew Smythe catheter, an S shaped metal catheter. Although not often performed in Britain these days, this procedure is still useful in many parts of the world where access to caesarean section may be difficult. It is used for inducing a woman with an unstable lie when the fetal head is wandering out of the pelvis and needs to be stabilised.

Prostaglandins

The commonest method of induction in current use in the United Kingdom is with prostaglandin gel of pessaries placed high in the vagina. These hormones are the same as those produced by the uterus in early labour, so it is a more natural method than using oxytocic agents. Also, cells that have been primed with prostaglandin gel ate more likely to respond if intravenous oxytocin is needed.

Prostaglandins can be given intravenously, intramuscularly, orally, or vaginally, but the first three routes often produce severe side effects and are best avoided in labour. Currently, in Britain, 1 mg or 2 mg of prostaglandin [E.sub.2a] is given in a gel. It is absorbed into the circulation through the vaginal and cervical epithelium, returning in the blood supply to the uterus. An obstetrician or midwife starting an induction with prostaglandin gel should stay with the woman for 20-30 minutes in case of a myometrial overreaction, and cardiotocography monitoring of the fetus is wise.

If labour is not established and the cervix is not dilating after four to six hours, the same dose of prostaglandin gel may be repeated. After this, most obstetricians would advise a low rupture of the membranes a the cervix was sufficiently dilated, usually with Syntocinon intravenously. Such a mixture should be handled with care, with a midwife constantly in attendance to observe the strength of the uterine contractions.

Syntocinon

This synthetically produced oxytocic is given intravenously, with the dose titred against the myometrial response. For safety reasons either a very dilute solution is used of a mechanical pump is preset to inject small amounts of the concentrated agent into a dextrose saline drip. Rarely is Syntocinon used alone to induce labour; its help is more to augment existing labour after the artificial rupture of the membranes or stimulation with prostaglandin gel.

Success of induction

Insertion of prostaglandin gel into the vagina is probably the most successful method of induction overall, effective in over 90% of women. A combination of artificial rupture of the membranes and Syntocinon succeeds in 95% of women who are induced with a ripe cervix.

Failure to induce labour after correct administration of adequate doses should make the obstetrician rethink whether induction is really appropriate. If delivery is still indicated, should a caesarean section be performed? If the indications ate borderline, is it possible to postpone induction for a day or so?

This can most readily be done if the membranes have not been ruptured. Such action may cause psychological reactions and the woman needs careful counselling.

Risks of induction

Induction may fail and lead to the need for caesarean section.

Uterine hyperstimulation can follow induction with Syntocinon or prostaglandin gel and lead to fetal distress, causing hypoxic damage to the baby.

Multiparous women should be induced carefully as they have an increased risk of uterine rupture. Treatment is with tocolytics and, if the problem persists, immediate operative delivery.

Prolonged membrane rupture without delivery can result in intrauterine infection. This is less likely if labour follows within 12 hours.

If the presenting part is not well engaged, a prolapsed cord may occur with the first rush of amniotic fluid.

The risk of amniotic fluid embolism is increased.

Rarely, induction might precipitate delivery of an unexpectedly preterm infant. With ultrasound scanning in early pregnancy, this is rare.

After induction the risk of operative vaginal delivery is increased 1.5-fold and that of caesarean section is increased 1.8-fold. This may well be due to the condition indicating induction.

Conclusions

Induction of labour is a powerful tool in obstetric management. It should be used only when the benefits to fetus or mother of the baby outweigh those of the pregnancy continuing. When induction is used, there should be sound indications and a reasonable chance that it will succeed. Using prostaglandins on their own is probably the most useful overall method.

The second graph on the first page is adapted from Crowley (Cochrame Library, 1998). The pie chart is adapted from the Statistical Bulletin: NHS Maternity Statistics (Department of Health, 1997).

Luke Zander is senior lecturer in the department of general practice and primary care at Guy's, King's, and St Thomas's Hospitals Medical Schools.

The ABC of Labour Care is edited by Geoffrey Chamberlain, emeritus professor of obstetrics and gynaecology at the Singleton Hospital, Swansea. It will be published as a book in the summer.

Induction and augmentation

* Induction means starting labour

* Augmentation means enhancing a labour that has already started

Contraindications to induction

* Severe cephalopelvic disproportion

* Severe degree of placenta praevia

* Oblique or transverse lie

* Cervix [is less than] 4 on the Bishop's score(*)

(*) This contraindication may be overcome by ripening the cervix with prostaglandins and then proceeding to induction

Ripeness of cervix

A ripe cervix shows that a uterus is ready for labour when it is:

* Soft

* Taken up

* Dilated

* Central on the presenting part

[GRAPH OMITTED]

Major indications for induction of labour reported for England and Wales (1994-5) and percentage of women with such problems who were induced

Key references

* Allot H, Palmer C. Sweeping the membranes. Br J Obstet Gynaecol 1993;100:898-903.

* Bishop EH. Pelvic scoring for elective induction. Obstet Gynaecol 1964;24:267.

* Chamberlain G, Wraight A, Crowley P. Homebirths. Carnford: Parthenon Press, 1997:45.

* Managing post term pregnancy. Drug and Therapeutics Bulletin 1997;35:17-8.

* Department of Health. Report of confidential enquiry into maternal deaths 1991-1993. London: HMSO, 1996.

* Crowley P. Intervention to improve outcome from delivery, beyond term. Elective induction of labour at 41 + weeks' gestation. In: Cochrane Collaboration. Crochrane Library. Issue 2. Oxford: Update Software, 1998.

* Roberts L, Young K. Management of prolonged pregnancy--women's attitudes. Br J Obstet Gynaecol 1991;98:1102-6.

* O'Connor R. Induction of labour--not how but why. Br J Hosp Med 1994;52:559-62.

* Reichler A, Romem Y, Divon MY. Induction of labor. Curr Opin Obstet Gynecol 1995;7:432-6.

Induction is the stimulation of the uterus with the aim of starting labour to ensure delivery of the fetus at an appropriate time when the baby is thought to be safer outside the uterus than in it

BMJ 1999;318:995-8

COPYRIGHT 1999 British Medical Association
COPYRIGHT 2000 Gale Group

Return to Syntocinon
Home Contact Resources Exchange Links ebay